CDCA was initially detected only in trace amounts in urine, but was found in significant levels after the enzymatic assays above. These results support that CDCA is a precursor of γMCA in BA biosynthesis in piglets.
INTRODUCTION
BAs have an important role in the control of lipid, glucose and cholesterol homeostasis.
Synthesis of BAs is the major pathway for the metabolism of cholesterol and for the excretion of excess cholesterol in mammals. BAs are biosynthesized from cholesterol in a complex process that utilizes at least 16 enzymes (1) . BAs are remarkably diverse in structure and exist in many different forms in different species within mammals, but in the human, cholic acid (CA) and chenodeoxycholic acid (CDCA) are most common (2) . As the prime experimental model for human, the rat and mouse produce several additional BAs as primary BAs, which include ursodeoxycholic acid (UDCA), α-muricholic acid (αMCA) and β-muricholic acid (βMCA) (2) (3) (4) . The piglet is also a common model for human infants because of the similarities in gastrointestinal development between piglets and human infants (5) .
However, the domestic pig has been reported to be virtually unable to synthesize CA. As a substitute, γMCA (hyocholic acid), an isomer of CA, is synthesized in amounts equal to that of CA in human.
γMCA is considered to be a species-specific primary BA in the pig (6) . Another species-specific primary BA is ursodeoxycholic acid (UDCA, an isomer of CDCA) in bears (7) .
BAs constitute a large family of molecules composed of free BAs and their conjugated forms.
Secondary free BAs are biosynthesized from primary BAs by various reactions, such as dehydroxylation and epimerization (8) . Free BAs undergo further conjugation with two amino acids (glycine or taurine), sulfuric acid, glucose (Glc), glucuronic acid (GlcUA) or N-acetylglucosamine (GlcNAc) to form conjugated BAs. BA composition can differ significantly between species, between gender in some species, between neonatal and adult periods of life, and also between healthy humans and patients with disorders, such as liver disease (9, 10) . It has been reported that the inborn errors of BA formation involve isolated defects in the enzymes of the biosynthetic pathway (10) (11) (12) , and that most inborn errors of the BA biosynthetic pathway involve the synthesis of excess intermediates and/or their metabolites that are excreted in part in urine. Also, insulin-resistant individuals had a blunted increase in blood glycochenodeoxycholic acid in oral glucose tolerance test (13) . Hence, the differentiated quantification by guest, on www.jlr.org
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For the enzymatic assays ( Fig. 1) , Choloylglycine Hydrolase from Clostridium perfringens, sulfatase from Helix Pomatia (type H-1), β-Glucuronidase from Escherichia coli (type VII-A) and dsaccharic acid 1,4-lactone monohydrate used as glucuronidase inhibitor, sodium acetate, sodium phosphate, sodium hydroxide and hydrochloric acid were purchased from Sigma-Aldrich Chemical Co. (St.
Louis, MO). Thirty-four authentic standards of BAs were used in the study (Fig. 2) . Twenty-four of the standards were purchased from Steraloids, Inc. (Newport, RI): α-muricholic acid (αMCA), β-muricholic acid (βMCA), γ-muricholic acid (γMCA, HCA), ω-muricholic acid (ωMCA), murideoxycholic acid (MDCA), 5β-cholanic acid-3β, 12α-diol (isoDCA), 3-deoxycholic acid (3-DCA), isolithocholic acid (isoLCA), allolithocholic acid (alloLCA), taurocholic acid (T-CA), sodium tauro α-muricholic acid (T-αMCA), tauro β-muricholic acid (T-βMCA), sodium tauro γ-muricholic acid (T-γMCA sodium salt), taurohyodeoxycholic acid (T-HDCA), taurochenodeoxycholic acid (T-CDCA), tauroursodeoxycholic acid (T-UDCA), taurodeoxycholic acid (T-DCA) and taurolithocholic acid (T-LCA), sodium glycohyocholic acid (G-γMCA sodium salt), glycohyodeoxycholic acid (G-HDCA), sodium glycochenodeoxycholate (G-CDCA sodium salt), glycoursodeoxycholic acid (G-UDCA), glycodeoxycholic acid (G-DCA), glycolithocholic acid (G-LCA), Nine of the standards were obtained from Sigma-Aldrich Chemical Co.
(St. Louis, MO): cholic acid (CA), chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), deoxycholic acid (DCA), glycocholic acid (G-CA), hyodecholic acid (HDCA) and lithocholic acid (LCA). Three sulfate conjugate standards, chenodeoxycholic acid 3-sulfate disodium salt (CDCA-3S disodium salt), ursodeoxycholic acid 3-sulfate disodium salt (UDCA-3S disodium salt) and glycolithocholic acid 3-sulfate disodium salt (G-LCA-3S disodium salt) were purchased from Alsachim (Strasbourg, France). Formic acid (for mass spectrometry, Fluka) and acetonitrile (Chromasolv 
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Samples were derived from pig experiments previously described (15, 16) . Briefly, White × Dutch Landrace × Duroc sows were artificially inseminated. Newborn male piglets (n = 5) were allowed to suckle with a sow for the duration of the experiment. All animals were housed in the animal facilities of the Arkansas Children's Hospital Research Institute, an Association for the Assessment and Accreditation of Laboratory Animal Care-approved animal facility. Animal maintenance and experimental treatments were conducted in accordance with the ethical guidelines for animal research established and approved by the institutional Animal Care and Use Committee at University of Arkansas for Medical Sciences. Twenty-one day old piglets were fasted 6-8 hours following the last feeding and exsanguinated after anesthetization with isoflurane at 0800-1000 h. Urine samples were obtained from the bladder at sacrifice and stored at −70°C until analyzed. Pooled urine sample was made by combining urine from five piglets.
Enzymatic deconjugation and LC-MS/MS sample Preparation
βMCA was added to urine (300 pmol/ml) as an internal standard (IS) and the urine containing IS was used for enzymatic assays and its control sample. For preparation of control sample (Control), 0.5 ml urine with IS in 1.5 ml graduated microcentrifuge tube was frozen at -80 o C followed by lyophilization.
The powdered urine in the tube was added with 0.5 ml 80% MeOH/H 2 O and vortexed vigorously for 2 mins followed by sonication in ice water for 5 mins. The mixture was centrifuged at RCF (153393 x g) for 5 mins and the supernatant solution was carefully drawn out from tube. The extraction process was repeated 2 more times, the supernatants were combined, filtrated through a 17 mm 0.2 µm filter (National Scientific, TN, USA), and adjusted to exact 1.5 ml with 80% MeOH/H 2 O for LC-MS/MS analysis. The pellet was further extracted with pure MeOH (0.5 ml) and methanol:methylene chloride (1:2) (0.5 ml). These two extracts were analyzed by LC-MS for examining the efficiency of 3-time 80%
MeOH/H 2 O extractions.
Four enzymatic assays (Assay 1-4) were used to deconjugate BA conjugates, which included CGH, S&HI, CH&S and GUS (Fig. 1 with 500 µl of ice-cold methanol, and the mixture is evaporated to dryness under an N 2 stream, immediately. The same BA extraction procedure that was used for control sample preparation above was used here for extraction of BAs after enzymatic deconjugation. The hydrolysis rate of conjugates was determined by comparison of the peak areas between endogenous conjugates before and after enzymatic assays.
LC-MS/MS Analysis
LC-MS/MS was performed using a 4000 Q TRAP system (Applied Biosystems, Foster City, CA, To analyze the BAs in urine, 5 µl aliquot of urine extract that was equivalent to 1.67 µl of starting sample urine was injected into the LC-MS/MS instrument. Two LC conditions with the same LC solvent flow rate of 0.5 ml/min were used in the LC-MS/MS analysis to confirm the peak yielded by its typical 
Validation of quantitative determination
βMCA was not detected in piglet urine in our preliminary experiment and has a chemical structure similar to that of endogenous free BAs, primary BA γMCA and ωMCA. βMCA was used as internal standard (IS) for analysis of BAs in piglet urine. Individual stock solutions of BA standards were prepared at 3 µmol/ml in 80% MeOH/H 2 O containing 300 pmol/ml βMCA. Stock solutions were then diluted to the concentrations of 10000, 3000, 1000, 300, 100, 30, 10, 3 and 1 pmol/ml using 80%
MeOH/H 2 O containing 300 pmol/ml IS βMCA. Six concentrations were chosen according to the concentration of endogenous BAs in urine for establishment of six-point calibration curves. The peakarea ratio of each bile acid to the IS were used to construct calibration curves. Seventeen calibration curves were established for quantitative determination (ωMCA, γMCA, T-βMCA, T-γMCA, G-γMCA, MDCA, HDCA, CDCA, DCA, G-CDCA, G-HDCA, CDCA-3S disodium salt, alloLCA, LCA, T-LCA, G-LCA and G-LCA-3S disodium salt). Two quantitative methods were used to calculate the concentration of endogenous BAs in the present study. The concentration of individual BA compound was calculated using the peak-area ratio of each BA to the IS and its corresponding standard curve. When the standard of endogenous BA was not available, the standard curve of its structurally related BA standard was used (supplementary (Fig.1) . Data are expressed as mean ± SD (n = 3). The recovery (percent ± SD) of extraction was calculated as [IS recovery in urine sample/IS recovery in standard solution that used for standard curve] (n=18).
RESULTS

Extraction of BAs in urine and recovery
The methods for analysis of BAs in piglet urine included exhaustive extraction of BAs from urine (using several methods) and LC-MRM-MS analysis was used to monitor the efficiency of BA extraction. Da for N-acetylglucosaminide conjugates. While the common glucosides of bile acids are glucuronides, glucosides and N-acetylglucosaminides, it has been reported that bile acid galactosides also exist in the urine (22) . Therefore, it is also possible that the glucoside conjugate, which is identified by a neutral loss of 162 Da in LC-MRM-MS analysis, is a galactoside. The typical ion pairs derived from characteristic fragmentation patterns of different BA conjugates can be used by targeted LC-MRM-MS analysis, and this targeted MS analysis enhances the lower detection limit for BA conjugates in biological samples.
The enzymatic assays included CGH assay for taurine and glycine amidated conjugates, GUS assay for glycosidic conjugates, S&GI assay for sulfate conjugates, and CH&S assay for all forms of conjugates ( 
Identification of conjugates of trihydroxycholanoic acids
As shown in Fig. 4B , MRM ion pair m/z 514.6/124.0 yielded 3 peaks for possible taurine conjugates of tirOH BAs in control samples. Hydrolysis by CGH treatment resulted in a 77.00 ± 0.77% reduction of peak area of the major peak (8) and the elimination of the other two peaks (9, 10), permitting the identification of the three compounds of peaks 8-10 as T-triOH BAs. Co-injection of pig urine and standards indicated that the compound of peak 9 was T-βMCA ( Fig. 3B ). Six LC-peaks (11-16) and several tiny peaks were generated by scan of MRM ion pair m/z 464.6/74.0 for G-triOH BAs and the peaks were eliminated after the CGH treatment ( Fig. 4C) . Therefore, the compounds of peaks 11-16 were identified as G-triOH BAs. Co-injection of urine samples and standards indicated that the major peak 16
were G-γMCA ( Table 1 ). Seven peaks for glycosidic conjugates were detected by their respective MRM ion pairs (supplementary Table 1 ). Three of them (peaks 17-19)
from MRM m/z 583.7/407.4 were hydrolyzed by GUS ( Fig. 4D ) and identified as triOH-GlcUA. While one peak for triOH BA-Glc ( Fig. 4E ) and three peaks for triOH BA-GlcNAc ( Table 1 ). However, a peak for T-triOH BA-S (peak (Fig. 4L ), GUS and S&GI, an unsaturated T-triOH-S-GlcUA (peak 24) was identified in piglet urine. One peak for unsaturated T-triOH BA (peak 25) was generated by MRM m/z 510.6/124.0 in control sample and hydrolyzed by CGH treatment to liberate an unsaturated triOH BA (peak 25a) (Fig. 4M, N) . Thus, compound 25 was identified as taurine conjugate of unsaturated triOH BA. Since Δ 4 -3-oxo-steroid 5β-reductase is involved in BA biosynthetic pathway (11), the compounds of peaks 21, 22, 24, 25 and 25a were tentatively identified as Δ
Identification of conjugates of dihydroxycholanoic acids
Four peaks (30-33) for G-diOH BAs were found in urine by their typical MRM ion pair m/z 448.6/74.0 and eliminated by CGH treatment (Fig. 5Ba) . Comparison with the standards indicated that conjugates 32 and 33 were G-HDCA and G-CDCA, respectively (Fig. 3F) . As expected, a selected ion m/z 391.4 monitoring yielded several tiny peaks in urine sample and four of them (peaks 26-29) increased in the urine sample after CGH treatment (Fig. 5A) . Analysis of urine samples spiked with standards indicated that peaks 26-29 were MDCA, HDCA, CDCA and DCA, respectively (Fig. 3D ). HDCA and UDCA were shown in one peak in this LC condition (LC-condition-I). Using LC-condition-II, LC-peaks for HDCA and UDCA were separated, and HDCA had a longer Rt. than UDCA. GUS enzymatic deconjugation resulted in the substantial increase of peak intensity for free diOH BAs of peaks 26-29
( identified as CDCA-3S. Peak 43 was a tiny peak ( Fig. 5F ) and overlapped with that of standard UDCA-3S (Fig. 3G ). G-conjugates of UDCA and HDCA (Fig. 3F) had similar Rt., and HDCA and its Gconjugate was found in urine. Thus, the compound of peak 43 was tentatively identified as HDCA-3S even though peak 43 was overlapped with UDCA-3S peak. Though the peak at Rt. 2.70 min was hydrolyzed by S&GI, it was also hydrolyzed by CGH (Fig. 5F) (Fig. 5G) . However, the enzymatic deconjugation of compounds 47 and 48 strongly suggested that these compounds were T-diOH BA-S. As shown in Fig. 5F -G, CGH deconjugation caused a nearly ten-fold decrease of peak intensity of T-diOH BA-3S (peaks 46-48) and a more than two-fold increase of the peak intensity of diOH BA-S (peaks 43-45), which led to identification of peaks 46-48 as T-diOH BA-S. Comparison of the profiles of T-diOH-S in control and diOH-S after CGH deconjugation, it is reasonable to assume that peaks 46 and 48 are the taurine conjugates of UDCA-3S (peak 43) and CDCA-3S (peak 45), respectively. An unsaturated T-diOH BA-S (49) and two GlcNAc conjugates of T-diOH BA-S (peaks 50 and 51) were also detected by their multiple typical MRM ion pairs scan and enzyme assays (Fig. 5H, I ). Total 25 diOH BAs were detected in piglet urine, which included 4 FBAs, 20 conjugated BAs and 1 unsaturated BA. detected in control sample and eliminated by CGH deconjugation (Fig. 6B, C) , which was in line with a more than two-fold increase of the intensity of peak 52 and mild increase of peak 53 (Fig. 6A Table 1 ), and the conclusion were confirmed by unaffected free tetraOH BA in GUS assay ( , and the peaks were enzymatically hydrolyzed by CGH and GUS (Fig. 6F) . The results led to the identification of these two compounds (peaks 66 and 67) as T-tetraOH BA-S. Also, TtetraOH BA-S's GlcUA conjugates (peaks 68 and 69), GlcNAc conjugates (peaks 71 and 72) and Glc conjugates (peak 75) were identified by their multiple typical MRM ion pairs and enzymatic deconjugation in CGH, GUS, S&HI and CH&S (Fig. 6G, I , K). The glycosidic conjugates of T-tetraOH-S (peaks 68, 69, 71, 72 and 75) were in triple conjugate form and had high levels in control (Fig. 6G, I , K). CH&S treatment deconjugated these conjugates of triple conjugate form and led a more than sevenfold increase of free tetraOH BAs (Fig. 6A from CH&S) , which confirmed the structural assignments for (Table 1) . Furthermore, the same procedure identified their corresponding unsaturated BAs, such as T-tetraOH BA-∆-S-GlcUA (peak 70), T-tetraOH BA-∆-S-GlcNAc (peaks 73
Identification of conjugates of tetrahydroxycholanoic acids
and 74) and T-tetraOH BA-∆-S-GlcUA (peak 76) (Fig. 6H, J were characterized in piglet urine ( Table 1) .
Identification of conjugates of monohydroxycholanoic acids
As shown in Figure 7A and B, the selected ion [M-H] -monitoring detected two peaks (77 and 78)
for monoOH BAs in control sample, and compounds of peaks 77 and 78 were identified as alloLCA and LCA by co-injection of sample and standard in LC-MS analysis (Fig. 3H) . Also, two peaks (79 and 80)
were detected for glycine conjugates of monoOH BAs. Enzymatic deconjugation using CGH resulted in the hydrolysis of these two compounds (Fig. 7B ) and the increase of the peaks of 77 and 78 after CGH assay ( Fig. 7A from CGH assay) . However, the increase was too small (Fig. 7A from CGH) for the hydrolyzed conjugates of the peaks of 79 and 80 (Fig. 7B) . Also, standard comparison indicated that the compounds of peaks 79 and 80 were not G-LCA (Fig. 3J) . Thus, the compounds of peaks 79 and 80 were tentatively identified as glycine conjugates of monoOH BAs. As neither nuclear magnetic resonance (NMR) data of these minor compounds nor their standards were available, identification of these compounds could not be completed by LC-MRM-MS analysis in this study. (Fig. 7D, E) . Elimination of all five peaks (82-86) after GUS deconjugation suggested that they were GlcUA conjugates. Furthermore, CGH treatment totally hydrolyzed the compounds of peaks 85 and 86. In agreement with the hydrolysis of T-monoOH BA-GlcUA of the peaks 85 and 86 by CGH treatment, CGH treatment caused a more than two-fold increase of monoOH BA-GlcUA peak 84 (Fig. 7D, E) , which indicated that peaks 85 and 86 were TmonoOH BA-GlcUA. G-monoOH BA-GlcUA was not detected in the piglet urine and in the samples after CGH and GUS enzymatic deconjugation. Monohydroxylated BA has been reported to have two potential glucuronidation sites: the 3-hydroxy group and the side chain carboxyl group (29), and compounds 82-86 should be 3-0-or carboxyl-attached glucuronides of LCA. However, their particular glucuronidation sites could not be determined without their authentic standards in the present study.
Quantitative determination
In this study, two quantitative methods were used to calculate the concentrations of endogenous BAs. In the first method, the concentration of each individual BA was calculated using the ratio of its peak-area to the IS and its corresponding standard curve (supplementary Table 2 ). The concentrations of the individual BAs are presented in Table 1 . BAs are remarkably diverse in structure and exist in the piglet urine, and BA standards were not available for all detected BAs, in which case the concentration of a detected BA was calculated using the standard curve of a structurally related BA standard. However, the calculated concentration may differ depending on which structurally related standard was chosen. For example, given the peak area of an analyte, the concentration of the analyte calculated using the T-γMCA standard curve would be 43 times higher than that calculated using the G-γMCA standard curve (supplementary Table 2 ) even though both T-γMCA and G-γMCA are in the amidated form with the only difference between them being that they are amidated with different amino acids. Thus, the concentration of an analyte calculated using the standard curve of a structurally related standard might be different from the analyte's real concentration in urine due to the difference in sensitivity between the analyte and the structurally related standard in LC-MRM-MS analysis (supplementary Table 2 ).
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In the second method, the concentration of each conjugate group was determined by the FBAs liberated from enzymatic deconjugation. Conjugates were hydrolyzed by four enzymatic assays: CGH for amidated conjugates (taurine and glycine), GUS for glycosidic conjugates, S&GI for sulfate conjugates, and CH&S for all forms of conjugates (Fig.1) . The results are shown in Fig. 8 . initially detected only in trace amounts in urine, but were found in significant levels after the enzymatic assays above (Fig. 8C) . The most abundant diOH BAs released by CH&S treatment was HDCA (2.19 ± 0.17 µmol/l), and the concentration of released CDCA was 0.24 ± 0.01 µmol/l.
DISCUSSION
The purpose of the present work is to obtain a comprehensive profile of urinary BAs in piglets, an animal model increasingly common in studies of postnatal development and nutrition. However, in the absence of a corresponding standard for a particular BA, a non-BA compound in the biological sample would be mistakenly identified as the BA if the MS of the non-BA compound contains the same molecular weight and product ion as that of a typical MRM ion pair for the BA. Therefore, herein we present a method for identifying and quantitating BAs, especially in the absence of their corresponding standards. This method identifies conjugated BAs using a two-step process: 1) the typical MRM ion pairs (supplementary Table 1 ) were used to scan the BA conjugates in urine and yielded the peaks of potential BA conjugates; and 2) four enzymatic assays were used to deconjugate the conjugated BAs and examined the changes of possible BA peaks by LC-MRM-MS analysis. The MRM peaks for conjugated BAs in urine that were diminished or eliminated and liberated new BA peaks by enzymatic treatment were considered as conjugated BAs. For example, as shown in Fig. 4E and F, two good peaks for Glc and GlcNAc conjugates of triOH BAs were generated by their typical MRM ion pairs, respectively. These two peaks were not considered to be glycosidic conjugates since they were not affected by GUS. On the other hand, peaks 17-19 were identified as GlcUA conjugates of triOH BAs because compounds 17-19 were hydrolyzed (Fig. 4D) and concomitantly released the free triOH BAs (Fig. 8A) by GUS treatment. In the present study, enzymatic deconjugation was used as additional evidence for confirming the identification of BAs in urine. Also, multiple typical MRM ion pairs were used for the identification of BAs in multiple conjugated form in this study (Fig. 4G, K The primary BAs in most mammals are CA and CDCA, and the CYP8B subfamily is required for introduction of a 12α-hydroxyl group to CDCA in CA biosynthesis. However, it is known that the domestic pig does not synthesize CA (6) . The enzyme (CYP4A21) catalyzing the 6α-hydroxylation in γMCA biosynthesis, an atypical member of the CYP4A subfamily, was found in pig (6, 30 ). An isomer of CA, 3α,6α,7α-trihydroxy-5β-cholanoic acid (γMCA) is the major BA constituent of porcine bile and considered to be a species-specific primary BA in the pig. Hence, the identification of γMCA as a dominant urinary BA component (81.94 ± 0.70% of FBAs in urine) in the present study is consistent with the literature (6) . CDCA is considered to a precursor of γMCA biosynthesis using 6α-hydroxylase (CYP4A21), and it is expected that the ratio between γMCA and CDCA in pigs is comparable to that of CA and CDCA in most other mammals (6) . In the present study, free diOH BAs including CDCA were only detected in trace amount in urine by a selected ion m/z 391.4, and the ratio between γMCA and CDCA in pigs is not comparable to that of CA and CDCA in most other mammals. However, twenty-two conjugates of diOH BAs were identified in urine (Table 1 ) and a significant level of CDCA was found after enzymatic deconjugation (Fig. 5A, 8C ), which supported a role of CDCA in biosynthesis of BAs and, more specifically, in the biosynthesis of γMCA via the action of 6α-hydroxylase (CYP4A21). Also, CYP3A4 has been reported to be involved in 6α-hydroxylation of both taurochenodeoxycholic acid and lithocholic acid (31). For the secondary free BAs, 6 triOH BAs, 3 diOH BAs, 6 tetraOH BAs and 2 monoOH BAs were detected, which may be biosynthesized from primary BA γMCA and CDCA by epimerization, hydroxylation and dehydroxylation, respectively. Table 1 and Fig. 8 . Liberated FBAs from urinary BA conjugates by CH&S treatment was 23.50 ± 2.46 µmol/l, which represented 70.25 ± 2.44% of urinary BAs. The conjugated BAs in triple conjugated forms are the most hydrophilic BAs and constituted a major portion of the urinary BAs in piglets ( Table 1) . Identification of glycine and taurine conjugates of unsaturated BAs have been reported in urine of children with defects in the gene or promoter region of Δ 4 -3-oxo-steroid 5β-reductase (gene AKR1D1) (11) . Nine conjugates of unsaturated BAs were detected in this study and suggested an involvement of Δ 4 -3-oxo-steroid 5β-reductase in biosynthesis of BAs in piglets.
Biosynthesis of BAs from cholesterol results in accumulation of
In summary, a method using a combination of enzymatic deconjugation and targeted LC-MRM-MS analysis was developed for analyzing BA conjugates in piglet urine. Four enzymatic assays were used to deconjugate BA conjugates: CGH for taurine and glycine amidated conjugates, GUS for glycosidic conjugates, S&GI for sulfate conjugates, and CH&S for all forms of conjugates (Fig.1) .
γMCA, an isomer of CA, was identified as a predominant FBA in female piglet urine, which agrees with the previous report that γMCA is a species-specific primary BA in the pig (6) . CDCA was detected only in trace amounts in urine before the enzymatic assays, but was found in a significant amount after the enzymatic assays, which supports that CDCA is a precursor of γMCA in BA biosynthesis in piglets. A high concentration of conjugated BAs in double and triple conjugated forms in urine suggests that multiple conjugated forms constitute one of the major pathways for the excretion of excess cholesterol.
Furthermore, the developed method also can be used in detection of other classes of metabolites in single and multiple conjugated forms where their standards are unavailable. Table S1 (Fig. 3B, C, E-G, I-K) of bile acids from co-injection of female piglet urine extract and standards. S1-S34 were BA standards. S1: ωMCA, S2: αMCA, S3: βMCA, S4: γMCA, S5: CA, S6: T-αMCA, S7:
T-βMCA, S8: T-γMCA, S9: T-CA, S10: G-γMCA, S11: G-CA, S12: MDCA, S13: UDCA, S14: HDCA, S15: isoDCA, S16: CDCA, S17: DCA, S18: 3-DCA, S19: T-UDCA, S20: HDCA, S21: T-CDCA, S22: In urine as Control 
